Completed NA INTERVENTIONAL NCT01008540

Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients (PHRC CMV)

Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients in the Prophylaxis Era, a French Multicentric Cohort Study

Sponsor: University Hospital, Limoges

Conditions Cytomegalovirus

Interventions depistage

Updated 7 times since 2017 Last updated: Jul 17, 2025 Started: Aug 31, 2006 Primary completion: Dec 31, 2010 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cytomegalovirus and is currently completed. University Hospital, Limoges leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Aug 2025 — Sep 2025 [monthly]

Completed NA
Sep 2024 — Aug 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Limoges

Data source: University Hospital, Limoges

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Angers, France , Besançon, France , Bobigny, France , Bordeaux, France , Brest, France , Caen, France , Clermont-Ferrand, France , Dijon, France , Fort de France, France and 19 more locations